We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.14%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.64%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XRAY icon
1326
Dentsply Sirona
XRAY
$2.32B
$14.5M ﹤0.01%
582,498
+61,077
+12% +$1.75M
JWN
1327
DELISTED
Nordstrom
JWN
$14.5M ﹤0.01%
682,799
+73,531
+12% +$1.5M
SCZ icon
1328
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
$14.5M ﹤0.01%
234,734
-46,901
-17% -$2.94M
CALX icon
1329
Calix
CALX
$2.4B
$14.4M ﹤0.01%
407,543
-5,535
-1% -$178K
THG icon
1330
Hanover Insurance
THG
$7.86B
$14.4M ﹤0.01%
115,078
-15,395
-12% -$2M
COTY icon
1331
Coty
COTY
$2.51B
$14.4M ﹤0.01%
1,439,108
-11,811
-0.8% -$127K
IART icon
1332
Integra LifeSciences
IART
$1.33B
$14.4M ﹤0.01%
493,719
+322,904
+189% +$9.58M
BBIO icon
1333
BridgeBio Pharma
BBIO
$16.6B
$14.4M ﹤0.01%
567,681
+256,322
+82% +$7.01M
FRO icon
1334
Frontline
FRO
$8.56B
$14.4M ﹤0.01%
546,937
+438,010
+402% +$11.2M
THRM icon
1335
Gentherm
THRM
$1.27B
$14.4M ﹤0.01%
291,186
-39,044
-12% -$2.02M
KNSA icon
1336
Kiniksa Pharmaceuticals
KNSA
$5.97B
$14.3M ﹤0.01%
766,411
-64,688
-8% -$1.21M
WKC icon
1337
World Kinect Corp
WKC
$1.89B
$14.2M ﹤0.01%
551,740
-17,245
-3% -$436K
SNV
1338
DELISTED
Synovus
SNV
$14.2M ﹤0.01%
353,516
-13,004
-4% -$493K
PRGO icon
1339
Perrigo
PRGO
$1.75B
$14.2M ﹤0.01%
554,656
+24,923
+5% +$732K
EPD icon
1340
Enterprise Products Partners
EPD
$82B
$14.2M ﹤0.01%
491,405
-141,566
-22% -$4.06M
WTM icon
1341
White Mountains Insurance
WTM
$5.04B
$14.2M ﹤0.01%
7,832
+2,507
+47% +$4.43M
SWTX
1342
DELISTED
SpringWorks Therapeutics
SWTX
$14.2M ﹤0.01%
375,664
+192,853
+105% +$8.12M
BILL icon
1343
BILL Holdings
BILL
$4.91B
$14.1M ﹤0.01%
268,727
+178
+0.1% +$10.1K
PD icon
1344
PagerDuty
PD
$916M
$14.1M ﹤0.01%
616,505
+385,150
+166% +$8.02M
HPP
1345
Hudson Pacific Properties
HPP
$740M
$14.1M ﹤0.01%
418,029
+46,419
+12% +$1.75M
VRRM icon
1346
Verra Mobility
VRRM
$720M
$14M ﹤0.01%
516,509
-1,883
-0.4% -$48.6K
VIRT icon
1347
Virtu Financial
VIRT
$4.92B
$14M ﹤0.01%
625,642
-22,109
-3% -$493K
BPOP icon
1348
Popular Inc
BPOP
$11.1B
$14M ﹤0.01%
158,191
-22,315
-12% -$1.94M
TOWN icon
1349
Towne Bank
TOWN
$3.4B
$14M ﹤0.01%
513,013
+70,177
+16% +$1.89M
CVSA
1350
Covista Inc
CVSA
$4.38B
$14M ﹤0.01%
204,614
+86,728
+74% +$5.09M

Similar funds

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.